The Livongo Health In Touch Blood Glucose Monitoring System (BGMS)
Recall Z-1587-2016, part of FDA recall event 73486. See Livongo Health's company page.
Livongo Health started this Class II device recall on Feb 18, 2016 (voluntary: firm initiated); FDA lists it as terminated, terminated Mar 6, 2018.
- Classification: Class II
- Started: Feb 18, 2016
- Status: Terminated
The instructional insert for the In Touch Control Solution for use with the In Touch meter and In Touch strips as a quality control check did not contain the limitation of sensor accuracy: (1) with the use of acetaminophen (Tylenol) (2) with the use of Ascorbic Acid (vitamin C) supplementation (3) in the presence of uric acid
- Product
- The Livongo Health In Touch Blood Glucose Monitoring System (BGMS), is an Over-The-Counter (OTC) system designed for the self- monitoring of blood glucose by persons with diabetes in home settings to aid in their diabetes management.
- Quantity
- 63,000 units
- Lots and codes
- Model/Reorder Number 3614-001-001 with the following lot numbers 890071 890072, 890073, 890074, 890075, 890076, 890077, 890078 and 890079.
- Distribution
- US consignees: Arizona, California, Delaware, Florida, Georgia, Illinois, Kentucky, Maryland, Michigan, Minnesota, Mississippi, Missouri, Montana, New Jersey, New York, Ohio, Pennsylvania, South Carolina, Tennessee, Texas, Virginia and Washington.
- Recalling firm
- Livongo Health, Chicago, IL, United States
- How the firm notified
- Letter
- FDA classified
- Apr 29, 2016
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports